Faster and Safer Paths to New Treatments in Medicines and Medical Devices
1 & 2 March 2016, Crowne Plaza Le Palace, Brussels, Belgium
Building faster but safe paths to new treatments: How do we safely develop new medicines and devices?
History and very recent events demonstrate and reinforce the need for rapid but safe development of medicines and devices. The aim of our 2016 annual conference is to explore how medicines and devices can be developed speedily but safely for patient benefit on a sound evidence base within the current and changing regulatory European frameworks.
Given the importance of human factor in the application of medicines and medical devices, one plenary session will be dedicated to human factors in treatments -- clinician expertise / patient adherence -- in medicines and medical devices, gathering regulators, physicians, patient representatives, academics, and industry representatives.
The European Forum for Good Clinical Practice has a long and successful history, acting as a forum to bring patients, researchers, sponsors, competent authorities and ethics committees together to debate current topics and provide rational approaches. It is one of the most important European fora for multi stakeholder debate and this meeting is designed to help pharmaceuticals and devices research learn from each other’s histories, hear patient voices and understand this changing regulations.
The tangible outcomes will be an EFGCP report and recommendations that will be provided to those involved in the legislative process.